These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 32410552

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Solid lipid nanoparticles and nanostructured lipid carriers--innovative generations of solid lipid carriers.
    Shidhaye SS, Vaidya R, Sutar S, Patwardhan A, Kadam VJ.
    Curr Drug Deliv; 2008 Oct; 5(4):324-31. PubMed ID: 18855604
    [Abstract] [Full Text] [Related]

  • 5. Current State of Lipid Nanoparticles (SLN and NLC) for Skin Applications.
    Eroğlu C, Sinani G, Ulker Z.
    Curr Pharm Des; 2023 Oct; 29(21):1632-1644. PubMed ID: 37534479
    [Abstract] [Full Text] [Related]

  • 6. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.
    Pardeike J, Hommoss A, Müller RH.
    Int J Pharm; 2009 Jan 21; 366(1-2):170-84. PubMed ID: 18992314
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Influence of lipid matrix composition on biopharmaceutical properties of lipid nanoparticles.
    Keck CM, Specht D, Brüßler J.
    J Control Release; 2021 Oct 10; 338():149-163. PubMed ID: 34389366
    [Abstract] [Full Text] [Related]

  • 10. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
    Fang JY, Fang CL, Liu CH, Su YH.
    Eur J Pharm Biopharm; 2008 Oct 10; 70(2):633-40. PubMed ID: 18577447
    [Abstract] [Full Text] [Related]

  • 11. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review.
    Garcês A, Amaral MH, Sousa Lobo JM, Silva AC.
    Eur J Pharm Sci; 2018 Jan 15; 112():159-167. PubMed ID: 29183800
    [Abstract] [Full Text] [Related]

  • 12. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.
    Müller RH, Radtke M, Wissing SA.
    Adv Drug Deliv Rev; 2002 Nov 01; 54 Suppl 1():S131-55. PubMed ID: 12460720
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lipid-Based Nanoparticles as Carriers for Dermal Delivery of Antioxidants.
    Lucia M.
    Curr Drug Metab; 2017 Nov 01; 18(5):469-480. PubMed ID: 28228079
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Formulating SLN and NLC as Innovative Drug Delivery Systems for Non-Invasive Routes of Drug Administration.
    Fonseca-Santos B, Silva PB, Rigon RB, Sato MR, Chorilli M.
    Curr Med Chem; 2020 Nov 01; 27(22):3623-3656. PubMed ID: 31232233
    [Abstract] [Full Text] [Related]

  • 17. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy.
    Jores K, Haberland A, Wartewig S, Mäder K, Mehnert W.
    Pharm Res; 2005 Nov 01; 22(11):1887-97. PubMed ID: 16132349
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Are lipid nanoparticles really superior? A holistic proof of concept study.
    Wiemann S, Keck CM.
    Drug Deliv Transl Res; 2022 Jun 01; 12(6):1433-1444. PubMed ID: 34476767
    [Abstract] [Full Text] [Related]

  • 20. QbD guided early pharmaceutical development study: Production of lipid nanoparticles by high pressure homogenization for skin cancer treatment.
    Amasya G, Aksu B, Badilli U, Onay-Besikci A, Tarimci N.
    Int J Pharm; 2019 May 30; 563():110-121. PubMed ID: 30935913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.